September 25, 2016 1:19 AM ET

Biotechnology

Company Overview of ARMO Biosciences Inc.

Executive Profile

Peter Van Vlasselaer Ph.D.

Founder, Chief Executive Officer, President and Director, ARMO Biosciences Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 7 different industries.

See Board Relationships
57--

Background

Dr. Peter Van Vlasselaer, Ph.D., is the Founder, Chief Executive Officer and President of ARMO Biosciences Inc. Dr. Vlasselaer serves as an Executive Chairman at True North Therapeutics, Inc. He has been the Executive Chairman of the Board of Directors at iPierian, Inc. since September 9, 2011. He has been the Chairman of Executive Board at Redwood Bioscience, Inc., since October 2011 and is responsible for Redwood's drug and platform development. He served as Executive ...

Corporate Headquarters

575 Chesapeake Drive
Redwood City, California 94303

United States

Phone: 650-493-9300
Fax: --

Board Members Memberships

Executive Chairman of The Board of Directors
Chairman of Executive Board and Director
Founder, Chief Executive Officer, President and Director
Executive Chairman
Director

Education

PhD
Katholieke Universiteit Leuven
BS
Katholieke Universiteit Leuven

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ARMO Biosciences Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.